Search

Amit Te Goswamy

from Los Gatos, CA
Age ~63
Get Report
Also known as:
Amit J Goswamy, Amit A Goswamy, Anjal J Goswamy, Anjali Goswamy, Mamit Goswamy
Phone and address:
104 Milani Ct, Los Gatos, CA 95030
(408) 395-0770
Related to:
Juhi Goswamy, 36Anjali Goswamy, 62
Connected to:
Martha K Goswell, 82Deborah Y Goswick, 65Johnny R Goswick, 56Nathan M Goswick, 48Norman D Goswick, 46Tabitha Goswick, 34Tina L Goswick, 59Nelly Goswitz, 59Timothy W Gosy, 57Angelica B Gosz, 78

Amit Goswamy Phones & Addresses

  • 104 Milani Ct, Los Gatos, CA 95030 (408) 395-0770
  • Rochester, NY
  • Pittsford, NY
  • Stanford, CA
  • Santa Monica, CA
  • Parlin, NJ
  • Bloomfield Hills, MI
  • Holy City, CA
  • 104 Milani Ct, Los Gatos, CA 95030 (408) 398-3570

Work

Company: Chakshu research Nov 2002 to Apr 2010 Position: Chief executive officer

Education

Degree: Master of Business Administration, Masters School / High School: Stanford University Graduate School of Business 1989 to 1991

Skills

Pharmaceuticals • Clinical • Business Planning • Biotechnology • Entrepreneurship • Strategy Development • Start Ups • Corporate Development • Product Marketing • Business Strategy • Life Sciences • Marketing Strategy • Cross Functional Team Leadership • Product Strategy • Strategic Partnerships • Outsourcing • Commercialization • Technology Commercialization • Alliances • Product Management • Competitive Analysis • Strategy • Enterprise Software • Mobile Devices • Pharmaceutical Industry • Lifesciences • Program Management • Management • Leadership • Venture Capital • Business Development • Strategic Planning • Executive Management • Marketing • Product Development

Languages

Hindi

Emails

a***[email protected]

Industries

Pharmaceuticals

Resumes

Resumes

Amit Goswamy Photo 1

Chief Executive Officer

View page
Location:
San Francisco, CA
Industry:
Pharmaceuticals
Work:
Chakshu Research Nov 2002 - Apr 2010
Chief Executive Officer
Livionex Nov 2002 - Apr 2010
Chief Executive Officer
Spotlife Apr 1999 - Jun 2002
President
Mayasoft Corp Apr 1998 - Apr 1999
President
Pictra Jan 1997 - Mar 1998
Vice President Sales and Business Development
Education:
Stanford University Graduate School of Business 1989 - 1991
Master of Business Administration, Masters Doms, Iit Roorkee 1978 - 1982
Bachelor of Engineering, Bachelors
Skills:
Pharmaceuticals
Clinical
Business Planning
Biotechnology
Entrepreneurship
Strategy Development
Start Ups
Corporate Development
Product Marketing
Business Strategy
Life Sciences
Marketing Strategy
Cross Functional Team Leadership
Product Strategy
Strategic Partnerships
Outsourcing
Commercialization
Technology Commercialization
Alliances
Product Management
Competitive Analysis
Strategy
Enterprise Software
Mobile Devices
Pharmaceutical Industry
Lifesciences
Program Management
Management
Leadership
Venture Capital
Business Development
Strategic Planning
Executive Management
Marketing
Product Development
Languages:
Hindi

Business Records

Name / Title
Company / Classification
Phones & Addresses
Amit Goswamy
President
Livionex Inc
Business Services at Non-Commercial Site
104 Milani Ct, Los Gatos, CA 95030
Amit Goswamy
President
Convidence, Inc
104 Milani Ct, Los Gatos, CA 95030
Amit Goswamy
President
CHAKSHU RESEARCH, INC
Business Services, Nec, Nsk
130 Knowles Dr SUITE A, Los Gatos, CA 95032

Publications

Us Patents

Method And Formulation For Treating Adverse Biological Conditions

View page
US Patent:
20100209419, Aug 19, 2010
Filed:
Aug 17, 2009
Appl. No.:
12/583304
Inventors:
Rajiv Bhushan - Palo Alto CA, US
Jerry B. Gin - Sunnyvale CA, US
Amit Goswamy - Los Gatos CA, US
International Classification:
A61K 39/395
A61K 31/7088
A61K 38/16
A61K 38/43
A61P 43/00
A61K 31/715
US Classification:
4241331, 514 44 R, 514 44 A, 514 12, 424 941, 4241301, 514 54
Abstract:
A method for treatment of adverse biological conditions is provided, wherein a biologically active agent such as a macromolecular biomolecule, e.g., a nucleic acid or a peptidic compound, is administered to a subject in need of such treatment in a formulation containing a transport enhancer having the structure of formula (I)wherein Q, R, and Rare as defined herein. Methylsulfonylmethane (MSM) is a representative and preferred transport enhancer. Formulations are also provided.

Method And Topical Formulation For Treating Localized Edema

View page
US Patent:
20100063152, Mar 11, 2010
Filed:
Oct 19, 2009
Appl. No.:
12/581678
Inventors:
Rajiv Bhushan - Palo Alto CA, US
Jerry B. Gin - Sunnyvale CA, US
Amit Goswamy - Los Gatos CA, US
International Classification:
A61K 31/195
A61P 17/00
US Classification:
514566
Abstract:
Methods and formulations are provided for the treatment of localized edema, particularly localized edema resulting from chronic venous insufficiency. A metal ion sequestrant is topically administered to a subject afflicted with localized edema in combination with a permeation enhancer selected from methylsulfonylmethane and a combination of methylsulfonylmethane and dimethylsulfoxide. Topically administrable formulations for use in the aforementioned method are also provided.

Formulations Comprising Chelators, Permeation Enhancers And Hydroxyethyl Cellulose For Treating Ophthalmic Disorders

View page
US Patent:
20210085696, Mar 25, 2021
Filed:
Mar 13, 2019
Appl. No.:
16/967634
Inventors:
- Los Gatos CA, US
Jerry GIN - Sunnyvale CA, US
Amit GOSWAMY - Los Gatos CA, US
International Classification:
A61K 31/65
A61K 31/4706
A61K 47/20
A61K 47/38
A61K 47/32
A61K 47/18
Abstract:
An ophthalmic formulation, comprising a chelator (such as EDTA and its salts), and a transport enhancer (such as Methyl Sulfonyl Methane; MSM) and an effective amount of a viscoelastic polymer (such as hydroxymethyl cellulose; HEC) is provided. Together, the combination of the two substances unexpectedly and beneficially reduces discomfort associated with and increases efficacy of chelator/transport enhancer as compared to formulations without the viscoelastic polymer.

Antimicrobial Compositions

View page
US Patent:
20170215417, Aug 3, 2017
Filed:
Apr 10, 2017
Appl. No.:
15/484020
Inventors:
- Los Gatos CA, US
Jerry GIN - Sunnyvale CA, US
Amit GOSWAMY - Los Gatos CA, US
International Classification:
A01N 41/10
A61L 31/16
A61L 15/44
A61K 8/55
A61K 31/6615
A01N 57/12
A61K 8/46
A61K 31/10
A61K 8/365
A61K 31/194
A01N 37/36
A61K 8/44
A61K 31/198
A01N 37/44
A61Q 19/10
A61Q 15/00
A61Q 11/00
A61K 9/70
A61K 45/06
A61K 9/00
A61K 9/06
A61K 8/88
A61K 31/785
A01N 37/20
A61K 8/04
A61K 8/02
A61L 31/08
Abstract:
An anti-microbial composition, comprising a chelator (such as EDTA and its salts), and a transport enhancer (such as Methyl Sufonyl Methane; MSM) is provided. Together, the combination of the two substances unexpectedly and beneficially inhibits bacterial or fungal biofilms when administered to an area of microbial infection. Preferred formulations include spray, lotion, solution, gel, cream, ointment, soap, deodorant, surgical rinse, or dental rinse.

Methods And Topical Formulations For Treating Inflammation

View page
US Patent:
20170209400, Jul 27, 2017
Filed:
Apr 10, 2017
Appl. No.:
15/484058
Inventors:
- Los Gatos CA, US
Jerry GIN - Sunnyvale CA, US
Amit GOSWAMY - Los Gatos CA, US
International Classification:
A61K 31/195
A61K 45/06
A61K 9/107
A61K 9/00
A61K 47/20
Abstract:
Methods and formulations are provided for the treatment of localized edema, particularly localized edema resulting from chronic venous insufficiency. A metal ion sequestrant is topically administered to a subject afflicted with localized edema in combination with a permeation enhancer selected from methylsulfonylmethane and a combination of methylsulfonylmethane and dimethylsulfoxide. Topically administrable formulations for use in the aforementioned method are also provided.

Anti-Plaque Oral Compositions

View page
US Patent:
20150335557, Nov 26, 2015
Filed:
Dec 20, 2013
Appl. No.:
14/654524
Inventors:
Jerry GIN - Sunnyvale CA, US
Amit GOSWAMY - Los Gatos CA, US
International Classification:
A61K 8/46
A61K 8/88
A61Q 11/00
A61K 8/55
A61K 8/44
A61K 8/365
Abstract:
An antiplaque oral composition, such as a toothpaste, gel dentifrice, tooth powder, mouth-rinse or mouthwash, tooth hardener, anti-calculus composition, gum or lozenge, comprising a chelator (such as EDTA and its salts), and a transport enhancer (such as Methyl Sulfonyl Methane; MSM) are provided. Together, the combination of the two substances unexpectedly and beneficially removes dental plaque when brushed or applied on teeth and gums. Preferred compositions are toothpastes, gel dentifrices and mouth-rinses or mouthwashes. Also provided are processes of repeatedly applying such antiplaque oral compositions to the teeth to obtain the antiplaque benefits mentioned.

Treating Inflammatory Conditions And Improving Oral Hygiene Using Metal Modulators With Methylsulfonylmethane As Transport Enhancer

View page
US Patent:
20150132347, May 14, 2015
Filed:
May 3, 2013
Appl. No.:
14/398473
Inventors:
Rajiv Bhushan - Mountain View CA, US
Jerry Gin - Sunnyvale CA, US
Amit Goswamy - Los Gatos CA, US
International Classification:
A61K 8/46
A61Q 11/00
A61K 8/44
US Classification:
424401, 424 54
Abstract:
Oral formulations are provided for prevention and treatment of adverse oral conditions such as gingivitis, periodontal disease, removal of calculus to improve dental hygiene, and control of dental plaque and biofilm. Use of the formulations for prevention and treatment of other adverse oral conditions including inflammation and oxidative and/or free radical damage within the oral cavity are provided. Treatable conditions may relate to other conditions or diseases, including diabetes, AIDS and cancer. Oral formulations containing a biocompatible chelating agent, and a permeation enhancer such as methylsulfonylmethane (MSM) are disclosed. Components of the formulations are multifunctional and Generally Regarded As Safe.
Control profile
Amit Te Goswamy from Los Gatos, CA, age ~63 Get Report